Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cahayasakti Investindo Sukses Tbk. (CSIS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Cahayasakti Investindo Sukses Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Cahayasakti Investindo Sukses Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Cahayasakti Investindo Sukses Tbk. trades at Rp202 (market cap 365.96B, 1.86M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Cahayasakti Investindo Sukses Tbk. is far larger — about 2.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Cahayasakti Investindo Sukses Tbk. is more actively traded (1.86M versus 187.4K). Which is the better fit depends on your goals.

CSISOBAT
Market Cap
365.96B164.65B
Volume
1.86M187.4K
Lot
18.6K1.87K
Turnover
371.02M44.35M
Average Price
199.45236.67
Value
371.02M44.35M
Indicative Equilibrium Price
202242
Indicative Equilibrium Volume
54500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSIS
View details
OBAT
View details

About Cahayasakti Investindo Sukses Tbk.

PT Cahayasakti Investindo Sukses Tbk (the Company) was established based on the Deed of Notary Djurnawati Soetarmono, SH, No. 52 dated June 2, 1995. The Company belongs to a group of companies owned by PT Andalan Utama Bintara.

Read more on CSIS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT